在各市场之间对比单一化妆品物质
输入一个 INCI 名称、化学名称、CAS 或 EC 编号。该工具将欧盟附件证据、关联的成分身份和独立的官方国家记录合并为一份对比。
缺少本地记录会显示为证据缺口,绝不视为准许或安全性结论。
搜索确切身份
对比查询
ASIVATREP
在 13 个市场数据集中的 0 个找到了匹配的监管证据。
有证据的市场
0
证据缺口
13
国家记录
0
欧盟附件记录
0
未解析出匹配的监管记录。
请尝试使用确切的 CAS、EC 或官方 INCI 名称。此结果是已索引数据集中的证据缺口,并不证明该物质获准使用或安全。
已解析的身份证据
1 个匹配或报告的名称
ASIVATREP
按市场划分的监管证据
状态为我们数据集中最强的匹配记录。请打开记录查看确切条件和法律范围。
| 市场 | 结果 | 记录 | 数据集覆盖范围 | 后续操作 |
|---|---|---|---|---|
| European Union EU | 未找到匹配项 | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | 未找到匹配项 | 0 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative. |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
完成官方核实工作流程
成分证据只是其中一层。这些针对特定市场的步骤列出了作出合规决定之前仍需完成的核查。
European Union · Complete annex dataset
- Confirm the exact INCI/CAS/EC identity.
- Review every matching Annex II–VI row and its conditions.
- Check SCCS opinions, CMR/nanomaterial rules and later amendments.
- Verify product classification, claims, labelling and responsible-person duties.
Great Britain · Complete consolidated annex dataset
- Confirm INCI/CAS/EC identity.
- Review every current GB Annex II–VI match.
- Check commencement dates and later statutory instruments.
- Verify SCPN, responsible-person, safety-report and labelling duties.
Canada · Complete Hotlist snapshot
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
New Zealand · Complete schedules dataset
- Search exact identity across Schedules 4–8.
- Apply use, concentration and warning conditions.
- Check hazardous-substance classification and Group Standard scope.
- Confirm the latest legal instrument, not only the spreadsheet.
ASEAN · Complete regional annex dataset
- Search all ACD annexes by name and identifiers.
- Apply product type, maximum level and warning conditions.
- Confirm the target member state's adoption and transition date.
- Complete the local notification and responsible-company requirements.
China · Complete prohibited catalogues plus official-source workflow
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
Japan · Complete Standards appendices dataset
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
South Korea · Complete current appendix dataset
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
United States · Complete enumerated federal ingredient rules
- Search Part 700 and all relevant colour-additive parts.
- Confirm colour additive identity, permitted uses, limits and certification status.
- Assess safety and adulteration under the FD&C Act.
- Complete MoCRA facility/product, adverse-event and label obligations where applicable.
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
Brazil · Complete prohibited dataset plus current restricted-list workflow
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
- Confirm product class and current Cosmetics Rules/gazette amendments.
- Check all applicable parts of IS 4707 by exact identity.
- Apply Schedule S/other finished-product standards where relevant.
- Verify licence/import registration, labelling and testing requirements.
Saudi Arabia · Complete official list index
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
本对比能够和不能决定什么
1. 解析身份
CAS 和 EC 标记会被精确提取。名称搜索使用规范化的官方名称和关联的身份。
2. 对比证据
针对每个受支持的市场,分别显示最强的匹配状态和直接记录。
3. 完成核实
产品类型、浓度、纯度、警示语、宣称、分类及后续修订仍需官方审核。